Contagion Live News Network: Coronavirus Updates for March 10, 2020
Stay on top of coronavirus developments from March 10, 2020.
HHS Acts to Bolster Respirator Stockpile For COVID-19
HHS announced that they will purchase 500 million N95 respirators over the next 18 months.
The London Patient Remains in HIV Remission After 30 Months
The abstract authors report that both HIV viral load in plasma and proviral HIV DNA in CD4 cells have remained below levels of detection for up to 30 months.
Evaluating Multimonth Dispensing Models for ART
Reducing barriers to care is paramount for people living with HIV and one such barrier in some countries, such as Zimbabwe, is high treatment loads that affect health system efficiency.
New Jersey Confirms First Coronavirus Death in Bergen County
The state of New Jersey has confirmed its first COVID-19 death.
Is the End in Sight for DRC Ebola Outbreak?
The last confirmed patient with Ebola was discharged from care on March 4, 2020.
For Women With HIV, Dolutegravir Associated With Higher Postpartum Weight Over Efavirenz
Women living with HIV who are on an antiretroviral therapy regimen of dolutegravir experienced persistently higher weight postpartum compared with women on efavirenz in Botswana.
Travel Restrictions May Not Curb Coronavirus
Travel history may be useful as a fifth vital sign in detecting coronavirus or any novel infectious disease.
The Fate of Conferences: Should We Cancel Amid COVID-19?
The impact of COVID-19 has started to trickle into the sphere of conferences and large events.
Steffanie Strathdee, PhD: Preventing HIV Among People Who Inject Drugs
“There are structural drivers that are impeding prevention and treatment among people who inject drugs,” Strathdee said in an interview with Contagion®.
FDA Issues Coronavirus-Related Warning Letters
The FTC and FDA have issued 7 companies warning letters for marketing fraudulent COVID-19 products.
Community ART Especially Effective Compared With Clinic Care for African Men
For African men living with HIV who are not virally suppressed, community-based antiretroviral therapy (ART) significantly increased viral suppression compared with clinic-based ART.
Contagion Live News Network: Coronavirus Updates for March 9, 2020
Stay on top of coronavirus developments from March 9, 2020.
Cabotegravir and Rilpivirine Maintains Efficacy in FLAIR 96-Week Data
New Week 96 data from the FLAIR study indicate that once-monthly injections of cabotegravir and rilpivirine remains non-inferior and safe when compared with the daily, oral 3-drug regimen of ABC/DTG/3TC.
Thin-Film Vaccine Platform Could Revolutionize Vaccine Distribution and Access
A team of investigators inadvertently discovered a way to preserve vaccines at room temperature for long periods of time.
Prenatal Care, Universal Syphilis Screening Critical for US Women
A team of investigators hypothesized that prevalent syphilis infection in women with and without HIV may be a way to identify individuals who are at an elevated risk of a stillbirth over time.
Gaps Remain in Immediate ART Initiation in NYC Clinics
Despite the high level of knowledge surrounding immediate initiation of ART, the practice is not yet the standard of care across clinics in NYC.
ATLAS-2M: Long-Acting Cabotegravir/Rilpivirine Every 2 Months Noninferior to Monthly Dosing
An international team of investigators shares 48-week results from ATLAS-2M, which tested out every other month dosing of the intramuscular injection compared with monthly dosing.
Gastrointestinal Symptoms Could Be New Focus for Coronavirus Diagnosis
Two new papers highlight the importance of the gastrointestinal tract in symptoms and spread of coronavirus.
GS-9722 Generally Safe, Well-Tolerated in Two Studies
Investigators conducted 2 studies on intravenously administered GS-9722, 1 in HIV-negative participants and 1 in virally suppressed people with HIV.
Weighing PrEP Options: How Much Are We Willing to Pay for 'Better'?
A generic pre-exposure prophylaxis (PrEP) option would greatly expand coverage among vulnerable populations and may well be the most cost-effective and safe option.
Aetna and CVS Health Partner to Benefit Members Amid Coronavirus Outbreak
CVS Health is opening a Crisis Response Line to ease coronavirus-related anxiety.
Higher Hospital Admissions Among Patients With Repeat Antibiotic Use
A study evaluated whether frequent antibiotic use is associated with reduced infection related hospital admissions.
CDC Recommendations for Coronavirus Home Isolation with Pets
Pets are not currently known to spread coronavirus, according to the CDC.
Synergy Between Antibiotics and The Innate Immune System
Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects
Gottlieb Addresses Coronavirus at Miami Breast Cancer Conference
"We're going to have to figure out what our American approach is to this to and how we're going to take more aggressive mitigation steps," Scott Gottlieb, MD, said in his keynote address.
Washington Insurance Commissioner Orders Insurers to Cover COVID-19 Testing
All health carriers regulated by the Washington Insurance Commissioner must waive copays and deductibles for consumers requiring COVID-19 testing through May 4, according to an order issued Wednesday.
Not Just Masks: WHO Warns of Looming Shortages of PPE
The World Health Organization says tens of millions of medical masks, gloves, and goggles will be needed each month as healthcare professionals attempt to deal with the spread of COVID-19.
Report Documents Identification, Diagnosis and Management of First US Coronavirus Case
Since the hospitalization of this patient, there are a reported 12 coronavirus deaths in the United States, with the majority in Washington state.
The ID Pipeline: FDA Activity From the Week of March 1, 2020
Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of March 1, 2020.